2000-2015年76国WHO抗生素消耗与获取目标评估
基于IQVIA季度全国抽样调查数据,将2000至2015年76国抗生素消耗按AWaRe分类,分析各类别占比及获取-观察指数变化。获取类占比达60%的国家数由76%降至55%。
要点
- 观察类抗生素消耗增速远超获取类,尤其在中低收入国家。
- 达到WHO国家层面获取类占比≥60%目标的国家比例下降。
核心结论
- 观察类抗生素消耗快速上升,尤其在中低收入国家,反映抗菌药物管理面临挑战;若无政策变化,WHO国家层面目标难以实现。
研究设计与样本
- 基于IQVIA季度全国抽样调查数据,对76个国家2000至2015年抗生素消耗按AWaRe分类进行分析,计算各类别占比及获取-观察指数。
主要发现
- 41个中低收入国家中37个(90%)获取-观察相对消耗下降。
- 获取类占比至少60%的国家从2000年66国中的50国(76%)降至2015年76国中的42国(55%)。
关键数值与推荐
- WHO国家层面目标为获取类抗生素至少占全国抗生素总消耗的60%。
- WHO提出到2023年实现该60%目标。
临床怎么用
- AWaRe框架可作为监测抗菌药物管理及国家间公平获取有效抗生素的重要工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The WHO Access, Watch, and Reserve (AWaRe) antibiotic classification framework aims to balance appropriate access to antibiotics and stewardship. We aimed to identify how patterns of antibiotic consumption in each of the AWaRe categories changed across countries over 15 years. METHODS: Antibiotic consumption was classified into Access, Watch, and Reserve categories for 76 countries between 2000, and 2015, using quarterly national sample survey data obtained from IQVIA. We measured the proportion of antibiotic use in each category, and calculated the ratio of Access antibiotics to Watch antibiotics (access-to-watch index), for each country. FINDINGS: Between 2000, and 2015, global per-capita consumption of Watch antibiotics increased by 90·9% (from 3·3 to 6·3 defined daily doses per 1000 inhabitants per day [DIDs]) compared with an increase of 26·2% (from 8·4 to 10·6 DIDs) in Access antibiotics. The increase in Watch antibiotic consumption was greater in low-income and middle-income countries (LMICs; 165·0%; from 2·0 to 5·3 DIDs) than in high-income countries (HICs; 27·9%; from 6·1 to 7·8 DIDs). The access-to-watch index decreased by 38·5% over the study period globally (from 2·6 to 1·6); 46·7% decrease in LMICs (from 3·0 to 1·6) and 16·7% decrease in HICs (from 1·8 to 1·5), and 37 (90%) of 41 LMICs had a decrease in their relative access-to-watch consumption. The proportion of countries in which Access antibiotics represented at least 60% of their total antibiotic consumption (the WHO national-level target) decreased from 50 (76%) of 66 countries in 2000, to 42 (55%) of 76 countries in 2015. INTERPRETATION: Rapid increases in Watch antibiotic consumption, particularly in LMICs, reflect challenges in antibiotic stewardship. Without policy changes, the WHO national-level target of at least 60% of total antibiotic consumption being in the Access category by 2023, will be difficult to achieve. The AWaRe framework is an important measure of the effort to combat antimicrobial resistance and to ensure equal access to effective antibiotics between countries. FUNDING: US Centers for Disease Control and Prevention.
引用
- Klein EY, Milkowska-Shibata M, Tseng KK, et al. Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000-15: an analysis of pharmaceutical sales data. Lancet Infect Dis. 2020. PMID: 32717205. doi:10.1016/S1473-3099(20)30332-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。